TY  - GEN
AU  - Urba,Susan
AU  - van Herpen,Carla M L
AU  - Sahoo,Tarini Prasad
AU  - Shin,Dong M
AU  - Licitra,Lisa
AU  - Mezei,Klara
AU  - Reuter,Christoph
AU  - Hitt,Ricardo
AU  - Russo,Francesca
AU  - Chang,Shao-Chun
AU  - Hossain,Anwar M
AU  - Frimodt-Moller,Bente
AU  - Koustenis,Andrew
AU  - Hong,Ruey-Long
TI  - Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study
SN  - 1097-0142
PY  - 2012///1126
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Squamous Cell
KW  - drug therapy
KW  - Cisplatin
KW  - Double-Blind Method
KW  - Female
KW  - Glutamates
KW  - Guanine
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Pemetrexed
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.27449
ER  -